Chapter 7 (A case study of patients' organizations: between good
causes and hidden clients) provides empirical traction to a nascent
literature that has called attention to the potential influence of
transnational pharmaceutical companies in the surge of
right-to-health litigiousness in some Latin American countries.
Furthermore, I present a case study of the multifaceted linkages
between patients' organizations that provide pro bono litigation
support and transnational pharmaceutical companies. The findings of
this chapter are the result of an in-depth immersion in the practice
of right-to-health litigation. The "thick narrative" of how actual
litigants go about their work offers insights into the crisis of
right-to-health litigation in Colombia and Brazil.
You are not authenticated to view the full text of this chapter or article.
Get access to the full article by using one of the access options below.